Sandra (Sandee) Sutera Email & Phone Number
Who is Sandra (Sandee) Sutera? Overview
A concise factual answer block for searchers comparing this professional profile.
Sandra (Sandee) Sutera is listed as VP, Head of Program and Portfolio Management, Chief of Staff to the President of R and D at Tango Therapeutics, a with 168 employees, based in Greater Boston, United States. AeroLeads shows a matched LinkedIn profile for Sandra (Sandee) Sutera.
Sandra (Sandee) Sutera previously worked as VP, Head of Program & Portfolio Management, Chief of Staff to the President of R&D at Tango Therapeutics and Sr. Director, Head of Operations at Moderna. Sandra (Sandee) Sutera holds Bachelor Of Science (B.S.), Biochemistry from University Of Minnesota.
Email format at Tango Therapeutics
This section adds company-level context without repeating Sandra (Sandee) Sutera's masked contact details.
Review company-level records connected to Sandra (Sandee) Sutera before choosing the right outreach path.
About Sandra (Sandee) Sutera
➢ I’m Sandee. Other people say that I am a strong leader who significantly impacts team culture by fostering community and synergy. I am recognized for my accountability, integrity, and energy, and I approach complex tasks fearlessly. I excel in structuring efficient workstreams and building an inclusive and engaging culture. My ability to communicate complex concepts with clarity and poise makes me very effective. Additionally, I am known for driving growth and excellence, quickly adapting to new roles, and navigating challenges. Overall, I am seen as a powerhouse who consistently delivers results and am valued for being caring, genuine, supportive, driven, and adventurous.What I Do:➢ I'm a passionate head of Program Management & Strategic Operations, where I steer the ship of complex drug development programs from concept through commercialization➢ With a rich background in navigating the intricacies of various therapeutic areas—from Diabetes and Oncology to Public Health—I thrive on merging innovative ideas, strategic business objectives, and diverse teams to cultivate excellence in execution.➢ My hands-on experience spans the full spectrum of drug development. Why It Matters:➢ The journey from a drug’s conception to the pharmacy shelf is fraught with challenges. My role is to simplify this journey, ensuring our breakthroughs reach patients faster and more efficiently, ultimately fostering better health outcomes worldwide.Let’s Connect! Whether you're interested in discussing the future of biotech, looking for insights on managing complex portfolios, or exploring potential collaborations, I’m here for it.
Sandra (Sandee) Sutera's current company
Company context helps verify the profile and gives searchers a useful next step.
Sandra (Sandee) Sutera work experience
A career timeline built from the work history available for this profile.
Vp, Head Of Program & Portfolio Management, Chief Of Staff To The President Of R&D
Current
Sr. Director, Head Of Operations
Established a strategic operations team responsible for Alliance Management, Program Management, Research Operations, Laboratory Operations, and cultural engagement to drive progress on the Moderna Genomics long-term vision. Implemented infrastructure where none existed and unified cross-functional leadership to develop and execute cohesive plans for drug discovery and preclinical development. • Synchronized strategic imperatives with actionable work plans and goals in partnership with the CSO / GM, and Lead Team Members to set direction for Moderna Genomics.• Initiated comprehensive mechanisms for gathering feedback on operational pain points and generated solutions for improvements that contributed to a more efficient, cohesive, and high-performing organization.• Advanced innovative technology by collaborating with team leads to create roadmaps and goals. As project manager for discovery of a novel Prime Editor, developed a comprehensive strategy and integrated operational plan.• Served as the Alliance Manager for external partnership. Coordinated clear communication and alignment while working closely with the legal and business development teams to navigate contractual requirements and ensure compliance with the agreement. • Catalyzed cultural transformation by building a team of positive influencers responsible for inspiring togetherness, engagement, and meaningful change across all teams.• Managed and maintained a yearly operating budget of $60M including research spend, external spend, and headcount. Facilitated quarterly reforecasts in close collaboration with the Financial Planning and Analysis function.
Sr. Director, Head Of Program Management
Promoted to lead the Program Management Organization to support clinical development across the entire portfolio including Oncology, Rare Disease, and Infectious Disease. Managed the Respiratory Portfolio as a strategic partner to the Heads of Respiratory and Infectious Diseases Development.• Re-structured the PMO to align by therapeutic area, strategically hired and promoted Directors to lead each area and form the PM Lead Team. Scaled the team to 40 members.• Developed organizational and lead team charters, established robust infrastructure and standards for onboarding, training, and talent development. • Championed the scaling and continuous improvement of tools and processes for managing short and long-term forecasts for clinical trial material to inform investments decisions and strategic planning.• Fostered connections with senior leaders to establish roles/responsibilities and ways of working to synthesize and streamline cross-departmental operations for regulatory preparations, hand-offs from discovery and preclinical to clinical development, and collaborations with CMC.• Orchestrated seamless integration of the development efforts for a respiratory combination portfolio, which included the RSV, Flu and COVID programs. Led operations to ensure these programs worked together effectively. Fostered big-picture thinking, aided in decision-making processes, and promoted cohesion to ensure strategic alignment.
Sr. Director, Head Of Infectious Disease Program Management
Led Program Management for the Infectious Disease portfolio and acted as Lead PM for the COVID program. • Expanded the PM Team from 12 to 18 to support the Infectious Disease portfolio and continued to contribute to enhancements in organizational capabilities, tools, and processes.• Integrated into the COVID Program as lead PM. Revamped team operations to align with product development workstreams and maximize cross-functional integrations within the Franchise; Responded to organizational growth and implemented a sustainable PM staffing model that maintained institutional knowledge and leveraged standardized processes across Moderna.
Director, Head Of Late Development Program Management
Joined Moderna as a founding member of Program Management and Lead Program Manager for the CMV Program. Rapidly advanced to manage the Late Development PM Team. • Refined the program strategy and developed execution plans and team operating model to accelerate the development a Cytomegalovirus (CMV) vaccine. Drove Phase 2 and Phase 3 start-up including preparations for regulatory interactions. Shifted organizational focus from near to long-term goals by leveraging integrated development plans and Target Product Profiles with consideration for the competitive landscape.• Scaled the PM team from 3 to 12, working with the Head of Portfolio Analytics and Governance to implement a development program operating model, governance standards, and PM tools/processes. • Maximized productivity, fostered positive culture, ensured alignment and adaptability in rapidly changing landscape by developing and implementing PM team infrastructure and competency standards.
Team Leader, Pharmaceutical Project Management
Fostered an empowered team culture and developed Project Managers through strategic leadership and staffing while maintaining vital stakeholder relationships. Coached and mentored project managers to enhance leadership and capabilities, leading to successful portfolio delivery, milestone achievements, regulatory submissions and approvals, and product launches.• Progressed from managing a six-person early phase Oncology team to leading a 17-person team across the Diabetes portfolio, with expanded responsibilities in the International Business Unit.
Pharmaceutical Project Manager, Oncology
As the lead Program Manager for Verzenio® (HR+ HER2- metastatic breast cancer), built program from the ground up. Developed and executed strategies for progression into clinical trials, expansion into Phase 3, and preparation of the first new drug application.• Drove strategic vision and program execution to accelerate Verzenio® from preclinical stages into clinical studies and expand into Phase 3 and global markets.• Led a cross-functional team in preparing regulatory documents and operations for Breakthrough Therapy Designation and the first New Drug Application.• Initiated process improvements within the PM community while serving as a mentor and coach to peers.
Prior Experience In Pharmaceutical Project Management And Analytical Chemistry
Colleagues at Tango Therapeutics
Other employees you can reach at tangotx.com. View company contacts for 168 employees →
Kavya Iyer
Colleague at Tango TherapeuticsGreater Boston, United States
View →
SR
Seth Rice
Colleague at Tango TherapeuticsCambridge, Massachusetts, United States
View →
H(
Heidi (Sheehan) Rego
Colleague at Tango TherapeuticsGreater Boston, United States
View →
MP
Maxim Pimkin, Md, Phd
Colleague at Tango TherapeuticsBoston, Massachusetts, United States
View →
JM
Jacob Mcallister
Colleague at Tango TherapeuticsGreater Boston, United States
View →
GS
Geneva Sganga
Colleague at Tango TherapeuticsBoston, Massachusetts, United States
View →
MT
Meghan Torrence
Colleague at Tango TherapeuticsBoston, Massachusetts, United States
View →
AC
Auston Collins
Colleague at Tango TherapeuticsBoston, Massachusetts, United States
View →
KF
Katherine Finley
Colleague at Tango TherapeuticsFramingham, Massachusetts, United States
View →
KY
Kait Yankello
Colleague at Tango TherapeuticsBoston, Massachusetts, United States
View →
Sandra (Sandee) Sutera education
Bachelor Of Science (B.S.), Biochemistry
Education record
Minor, Chemistry
Other; Hmx Fundamentals Online Certificate Program - Immunology
Frequently asked questions about Sandra (Sandee) Sutera
Quick answers generated from the profile data available on this page.
What company does Sandra (Sandee) Sutera work for?
Sandra (Sandee) Sutera works for Tango Therapeutics.
What is Sandra (Sandee) Sutera's role at Tango Therapeutics?
Sandra (Sandee) Sutera is listed as VP, Head of Program and Portfolio Management, Chief of Staff to the President of R and D at Tango Therapeutics.
Where is Sandra (Sandee) Sutera based?
Sandra (Sandee) Sutera is based in Greater Boston, United States while working with Tango Therapeutics.
What companies has Sandra (Sandee) Sutera worked for?
Sandra (Sandee) Sutera has worked for Tango Therapeutics, Moderna, and Eli Lilly And Company.
Who are Sandra (Sandee) Sutera's colleagues at Tango Therapeutics?
Sandra (Sandee) Sutera's colleagues at Tango Therapeutics include Kavya Iyer, Seth Rice, Heidi (Sheehan) Rego, Maxim Pimkin, Md, Phd, and Jacob Mcallister.
How can I contact Sandra (Sandee) Sutera?
You can use AeroLeads to view verified contact signals for Sandra (Sandee) Sutera at Tango Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Sandra (Sandee) Sutera attend?
Sandra (Sandee) Sutera holds Bachelor Of Science (B.S.), Biochemistry from University Of Minnesota.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial